Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

41,479 stories, page 458 of 692

Advanced search

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries (TEVA) Projected to Post Earnings on Wednesday

MarketBeatOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

77,800 Shares in Teva Pharmaceutical Industries Ltd. $TEVA Acquired by Barometer Capital Management Inc.

MarketBeatOriginal source

🇺🇰Jul 22Researchquadram.ac.ukTier 2 · Direct publisher

Landmark for new tonsil biorepository

Quadram Institute (Bioscience)Original source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Biotech company files bankruptcy petition against smolt producer

intrafish.comOriginal source

🌍Jul 22Mediahealx.aiTier 2 · Direct publisher

Healx Announces First Patient Dosed in Phase 1/2 Trial to Evaluate the Effect of HLX-4310 on Metastatic Recurrence and Progression in Sarcomas with a Focus on Osteosarcoma

HealxOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Biotech Hair Growth Brand Re:You Launches

WWDOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

FIRST AID: A short week, biotech rolls on

euractiv.comOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Wegovy seeks Korea approval to treat MASH, expanding beyond obesity - CHOSUNBIZ

ChosunbizOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Singapore-based biotech startup Tikva Allocell closes $8 M Series A funding round

BioSpectrum AsiaOriginal source

🌍Jul 22Industryroyaltypharma.comTier 1 · Company source

Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune

NEW YORK, NY, July 22, 2026 — Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired...

Royalty PharmaOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Solvent Dehydration Chemicals Market to Reach USD 2,078.2 Million by 2036 as Pharmaceutical Manufacturing and High-Purity Solvent Recovery Accelerate Global Demand

24-7 Press Release NewswireOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Death of woman in New York from compounded drug shows the risk of allowing compounding of untested substances

Partnership for Safe MedicinesOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Hanmi Pharmaceutical Co., Ltd. – KRX:128940

TradingViewOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Armata Submits Phase 3 Protocol for AP-SA02 Bacteriophage in S. aureus Bacteremia

The Clinical Trial VanguardOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Major new pharmaceutical policy! US tariffs on generic drugs to double progressively, up to 200%

ChemNetOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Fugitive doctor on run for 21 years was living as L.A. biotech exec

KTLAOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Why is Sun Pharmaceutical Industries stock falling today?

Investing.comOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

FDA Warns of Recalled Allergy Drug Over Contamination Risk

Readers.idOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Beijing Aosaikang Pharmaceutical Co., Ltd. Class A – SZSE:002755

TradingViewOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

U.S. biotech CEO explains why he chose Hong Kong for primary listing

CNBCOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Aribio to Present AR1001 Phase 3 Clinical Trial Results at CTAD in November

Aju PressOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

ING podcast examines China’s biotech rise and shifting global pharma order

BioSpectrum AsiaOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Thailand courts Korean investment in biotech, wellness sectors

The Korea HeraldOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Lonza raises core profit margin target after solid first half

ReutersOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Where to find healthy profits in biotech

Yahoo FinanceOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Sex offender, a fugitive for 21 years, hid in plain sight as a yacht-owning L.A. biopharma exec

Los Angeles TimesOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Is Krystal Biotech (KRYS) Overvalued On Its KB801 Patent Data Update?

simplywall.stOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

The AI Ebb Gives Way to Biotech as Winners Emerge in the U.S. IPO Market

NAI500Original source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

BIO Asia-Taiwan 2026 Unites 60 Countries, Showcasing Taiwan as a Global Biotech Innovation Partner

PR NewswireOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Trump announces 100% tariffs on imported generic pharmaceutical drugs

France 24Original source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

MSD advances Korea-linked eye drug, starts four phase 3 trials vs Eylea - CHOSUNBIZ

ChosunbizOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Trump plans generic drug tariffs from 2028 with two-year delay testing U.S. onshoring push

CNBCOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Radiopharm (ASX:RAD) Advances RAD101 and RAD204 with Positive Clinical Trial Updates

Kalkine MediaOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Is Your Allergy Medicine Safe? FDA Recalls Antihistamine Tablets Over Life-Threatening Contamination Concerns

Health and MeOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Shapiro administration launches $125M fund for biotech startups

AudacyOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Trump Plans to Impose Tariffs on Generic Drugs

The New York TimesOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Trump says he will impose tariffs on generic drugs starting in August 2028

PoliticoOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Kolon TissueGene plunges again as US phase 3 for arthritis therapy fails - CHOSUNBIZ

ChosunbizOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

AriBio to present AR1001 phase 3 results at CTAD 2026 in Boston

koreabiomed.comOriginal source

🇸🇦Jul 22Regulatorysfda.gov.saTier 1 · Regulatory source

SFDA Grants Orphan Drug Designation to Gritgen Therapeutics for PKU Treatment

The Saudi Food and Drug Authority (SFDA) has granted orphan drug designation to Gritgen Therapeutics...

SFDA Saudi ArabiaOriginal source

🇺🇸Jul 22Regulatorysec.govTier 1 · Regulatory source

GSK filed Form 6-K

SEC EDGAROriginal source

🇺🇸Jul 22Regulatoryfederalregister.govTier 1 · Regulatory source

Submission for Office of Management and Budget Review; Generic for Administration for Children and Families Program Monitoring Activities

The Administration for Children and Families (ACF) intends to request from the Office of Management...

Federal RegisterOriginal source

🇺🇸Jul 22Regulatoryfederalregister.govTier 1 · Regulatory source

Determination That RASUVO (Methotrexate) Solution, 27.5 Milligrams/0.55 Milliliter (27.5 Milligrams/0.55 Milliliter), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness

The Food and Drug Administration (FDA, Agency, or we) has determined that RASUVO (methotrexate) solu...

Federal RegisterOriginal source

🇺🇸Jul 22Regulatoryfederalregister.govTier 1 · Regulatory source

Center for Scientific Review; Notice of Closed Meetings

Federal RegisterOriginal source

🇺🇸Jul 22Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Premarket Notifications Submission

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has b...

Federal RegisterOriginal source

🇺🇸Jul 22Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Advanced Nursing Education Program Specific Form OMB No. 0906-0089-Revision

In compliance with the requirement for opportunity for public comment on proposed data collection pr...

Federal RegisterOriginal source

🇺🇸Jul 22Regulatoryfederalregister.govTier 1 · Regulatory source

Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation

Cerilliant Corporation has applied to be registered as a bulk manufacturer of basic class(es) of con...

Federal RegisterOriginal source

🇫🇷Jul 22Devicesessilorluxottica.comTier 1 · Company source

EssilorLuxottica Expands its Readers Offering with New FGX Brand Partnerships

EssilorLuxotticaOriginal source

🌍Jul 22Industrybbbiotech.chTier 1 · Company source

24 Feb, 2026EXPERT COMMENTARYFrom innovation to value realization: The biotech market in a new phaseFind out more

After several years characterized by elevated capital costs, valuation pressure and pronounced risk...

BB BiotechOriginal source

🇫🇷Jul 22Industryvalneva.comTier 1 · Company source

Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026

ValnevaOriginal source

🇺🇸Jul 22Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Baclofen

Official structured record identifier: 3047613d-006b-4011-b5fe-098588f474aa.

openFDA Drug LabelsOriginal source

🇺🇸Jul 22Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Metronidazole

Official structured record identifier: 2f7d84d4-1085-4243-be88-442eecb85205.

openFDA Drug LabelsOriginal source

🇺🇸Jul 22Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: ondansetron

Official structured record identifier: 2edc0788-dc38-4d21-ba8e-71f159e2d3b1.

openFDA Drug LabelsOriginal source

🇺🇸Jul 22Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Gentle Laxative

Official structured record identifier: 29c2efc4-d297-46a0-8008-7a2fad9e8b88.

openFDA Drug LabelsOriginal source

🇺🇸Jul 22Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Metolazone

Official structured record identifier: 27ab833e-b809-4a80-b7fc-b3599f1751d3.

openFDA Drug LabelsOriginal source

🇺🇸Jul 22Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: First Aid Antiseptic

Official structured record identifier: 262ea2c8-f571-1c0b-e063-6394a90af20b.

openFDA Drug LabelsOriginal source

🇺🇸Jul 22Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: First Aid A and D

Official structured record identifier: 25a319d0-d39a-5ff0-e063-6394a90a671d.

openFDA Drug LabelsOriginal source

🇺🇸Jul 22Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Baby Vitamin A and D

Official structured record identifier: 25a125ea-6f9f-310c-e063-6394a90acef2.

openFDA Drug LabelsOriginal source

🇺🇸Jul 22Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Moisture Barrier

Official structured record identifier: 258f3392-0f42-21e8-e063-6294a90ae9ad.

openFDA Drug LabelsOriginal source

🇺🇸Jul 22Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Heat Pain Relief

Official structured record identifier: 2434f9cf-74aa-17af-e063-6294a90a56d9.

openFDA Drug LabelsOriginal source